Shares Magazine
166.00p+0.60 (+0.36%)23 Aug 2024, 17:09
Jump to:
Puretech Health PLC Fundamentals
| Company Name | Puretech Health PLC | Last Updated | 2024-08-23 |
|---|---|---|---|
| Industry | Biotechnology | Sector | Healthcare |
| Shares in Issue | 239.319 m | Market Cap | £397.27 m |
| PE Ratio | 227.27 | Dividend per Share | 0 |
| Dividend Yield | 0 | Dividend Cover | 0 |
| EPS | -$0.24 | EPS Growth (%) | 0 |
| PEG | 0 | DPS Growth (%) | 0 |
| Debt Ratio | 0.0365 | Debt Equity Ratio | 0.0393 |
| Asset Equity Ratio | 1.5145 | Cash Equity Ratio | 0.7139 |
| Quick Ratio | 6.4146 | Current Ratio | 6.76 |
| Price To Book Value | 1.1211 | ROCE | 0 |
Puretech Health PLC Dividends
| Type | Ex-Date | Pay Date | Currency | Net Dividend | Year Total |
|---|
Puretech Health PLC Company Financials
| Assets | 2023 | 2022 | 2021 |
|---|---|---|---|
| Tangible Assets | $19.36 m | $37.24 m | $43.94 m |
| Intangible Assets | $906,000.00 | $831,000.00 | $987,000.00 |
| Investments | $321.03 m | $261.04 m | $397.18 m |
| Total Fixed Assets | $346.77 m | $316.45 m | $444.20 m |
| Stocks | 0 | 0 | 0 |
| Debtors | $2.38 m | $11.87 m | $18.29 m |
| Cash & Equivalents | $327.14 m | $350.10 m | $465.71 m |
| Other Assets | $5.48 m | $17.35 m | $2.10 m |
| Total Assets | $693.97 m | $702.65 m | $946.01 m |
| Liabilities | 2023 | 2022 | 2021 |
|---|---|---|---|
| Creditors within 1 year | $51.37 m | $96.89 m | $226.13 m |
| Creditors after 1 year | $184.37 m | $58.17 m | $135.72 m |
| Other Liabilities | 0 | 0 | 0 |
| Total Liabilities | $235.74 m | $155.06 m | $361.86 m |
| Net assets | $458.23 m | $547.59 m | $584.15 m |
| Equity | 2023 | 2022 | 2021 |
|---|---|---|---|
| Called up share capital | $5.46 m | $5.46 m | $5.44 m |
| Share Premium | $290.26 m | $289.62 m | $289.30 m |
| Profit / Loss | -$36.10 m | -$92.78 m | -$58.95 m |
| Other Equity | $464.07 m | $542.22 m | $593.51 m |
| Preference & Minorities | -$5.83 m | $5.37 m | -$9.37 m |
| Total Capital Employed | $458.23 m | $547.59 m | $584.15 m |
| Ratios | 2023 | 2022 | 2021 |
|---|---|---|---|
| Debt Ratio | $0.04 | $0.06 | $0.07 |
| Debt-to-Equity | $0.04 | $0.06 | $0.07 |
| Assets / Equity | 1.5145 | 1.5145 | 1.5145 |
| Cash / Equity | 0.7139 | 0.7139 | 0.7139 |
| EPS | -$0.57 | -$0.52 | -$0.64 |
| Cash Flow | 2023 | 2022 | 2021 |
|---|---|---|---|
| Cash from operating activities | -$105.92 m | -$178.79 m | -$158.27 m |
| Cashflow before financing | -$27.78 m | -$208.62 m | -$135.55 m |
| Increase in Cash | $41.22 m | -$315.84 m | $61.83 m |
| Income | 2023 | 2022 | 2021 |
|---|---|---|---|
| Turnover | $750,000.00 | $2.09 m | $9.98 m |
| Cost of sales | 0 | 0 | 0 |
| Gross Profit | 0 | 0 | 0 |
| Operating Profit | -$146.20 m | -$197.81 m | -$150.28 m |
| Pre-Tax profit | -$36.10 m | -$92.78 m | -$58.95 m |
Puretech Health PLC Company Background
| Sector | Healthcare |
|---|---|
| Activities | PureTech Health PLC is a biopharma company developing medicines to modulate the adaptive human system. It is a cross-disciplinary healthcare company developing products that could improve the lives of patients. The company is focused on developing and commercializing highly differentiated medicines for devastating diseases, including inflammatory, fibrotic, and immunological conditions, intractable cancers, lymphatic & gastrointestinal diseases, and neurological & neuropsychological disorders, among others. It operates in the following segments: Wholly-Owned Programs, Controlled Founded Entities, and Parent Companies & Others. The company has a robust pipeline of advanced programs that are post-human proof of concept and focused on some of society's healthcare needs. |
| Latest Interim Date | 28 Aug 2024 |
| Latest Fiscal Year End Date | 25 Apr 2024 |
Puretech Health PLC Directors
| Appointed | Name | Position |
|---|---|---|
| 2020-08-27 | Dr. Bennett M. Shapiro | Non-Executive Director |
| 2024-03-06 | Dr. Bharatt M. Chowrira | Executive Director,Chief Executive Officer |
| 2024-06-27 | Dr. John L. LaMattina, PhD | Non-Executive Director |
| 2024-06-27 | Dr. Robert S. Langer, Sc.D. | Non-Executive Director |
| 2024-06-27 | Dr. Raju S. Kucherlapati | Non-Executive Director,Chairman |
| 2019-09-09 | Mr. Joichi Ito | Non-Executive Director,Chairman |
| 2022-12-28 | Dame Marjorie Morris Scardino | Non-Executive Director,Senior Independent Director |
| 2024-04-25 | Mr. Christopher Viehbacher | Non-Executive Director,Chairman |
| 2024-06-27 | Ms. Kiran Mazumdar Shaw | Non-Executive Director |
| 2024-04-09 | Ms. Daphna Zohar | Executive Director,Chief Executive Officer |
| 2021-01-29 | Mr. Stephen Muniz | Executive Director,Chief Operating Officer and Company Secretary |
| 2024-06-27 | Ms. Sharon Barber-Lui | Non-Executive Director |
Puretech Health PLC Contact Details
| Company Name | PureTech Health PLC |
|---|---|
| Address | 6 St Andrew Street, 5th Floor, London, EC4A 3AE |
| Telephone | |
| Website | https://www.puretechhealth.com |
Puretech Health PLC Advisors
| Stockbroker | Peel Hunt LLP |
|---|---|
| Phone | +44 2074188900 |
| Stockbroker | Jefferies Hoare Govett |
|---|---|
| Phone | +44 2070298000 |
| Fax | +44 2070298010 |
| Stockbroker | Numis Securities Limited |
|---|---|
| Phone | +44 2072601000 |
| Remuneration Consultant | New Bridge Street |
|---|---|
| Phone | +44 2070869341 |
| Fax | +44 2070869341 |
| Financial PR Adviser | FTI Consulting Inc |
|---|---|
| Phone | +44 2037271000 |
| Fax | +44 2037271007 |
| Auditor | KPMG |
|---|---|
| Phone | +44 2073111000 |
| Fax | +44 2073113311 |
| Solicitor | DLA Piper LLP |
|---|---|
| Phone | +44 8700111111 |
| Fax | +44 2077966666 |
| Registrar | Computershare Investor Services PLC |
|---|---|
| Phone | +44 3707020003 |
| Fax | +44 3707036101 |
Receive our
daily news email
Subscribe to the latest investing news by entering your email address below
You can opt out at any time.
For five days a week you will get
- The latest company news
- Insight into investment trends
- Round-up of director's buys and sells
- Articles from Shares magazine
Plus more useful investment content and occasional promotional offers.
Market Overview
UK 350 Risers and Fallers
Risers
| Company | Price | % Chg |
|---|---|---|
| Jd Sports Fashion PLC | 149.25 | 5.22 |
| Hammerson PLC | 28.98 | 3.43 |
| B&M European Value Retail S.A. | 452.50 | 3.08 |
| Ithaca Energy PLC | 127.60 | 3.07 |
| Supermarket Income Reit PLC | 76.00 | 2.70 |
| Carnival PLC | 1,110.50 | 2.68 |
Fallers
| Company | Price | % Chg |
|---|---|---|
| Melrose Industries PLC | 474.70 | -7.10 |
| Renishaw PLC | 3,520.00 | -3.03 |
| Hays PLC | 95.25 | -2.21 |
| Bh Macro Limited | 362.50 | -2.03 |
| Direct Line Insurance Group PLC | 185.20 | -2.01 |
| Sage Group PLC | 996.20 | -2.00 |
Risers/fallers data from previous trading day.